HIGH

Teva Metoprolol Succinate 50 mg Extended-Release Recall 2026 Following Failed Dissolution Specs (67,

Teva Pharmaceuticals recalled 67,043 bottles of Metoprolol Succinate Extended-Release Tablets, 50 mg, distributed nationwide. The FDA enforcement report cites Failed Dissolution Specifications as the hazard. Health care providers and patients should stop using this product immediately and contact Teva for guidance.

Quick Facts at a Glance

Recall Date
January 29, 2026
Hazard Level
HIGH
Brands
METOPROLOL SUCCINATE, Actavis Pharma, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Metoprolol succinate extended-release tablets are used to treat high blood pressure and other heart-related conditions. They are prescribed and dispensed by healthcare professionals.

Why This Is Dangerous

The dissolution failure means the medicine may not release the active ingredient as designed, potentially reducing effectiveness or causing unpredictable effects.

Industry Context

This recall is not described as part of a broader industry pattern in the notice.

Real-World Impact

Patients may experience reduced therapeutic effect or unpredictable blood pressure control. The recall impacts a large nationwide distribution and requires immediate clinician guidance.

Practical Guidance

How to identify if yours is affected

  1. Check NDC: 45963-676-11 (100-tablet bottle) or 45963-676-96 (1,000-tablet bottle)
  2. Inspect lot numbers: a) 0486G251, 0487G251, 0488G251 with Exp. 01/2027; b) 0486G252, 0487G253, 0488G252 with Exp. 01/2027
  3. Look for name Metoprolol Succinate Extended-Release 50 mg on the bottle

Where to find product info

NDC and lot numbers are on the bottle label near the bottom or back panel.

What timeline to expect

Recall status is active. No specific replacement timeline provided. Monitor Teva FDA notices for updates.

If the manufacturer is unresponsive

  • Ask your healthcare provider for guidance if Teva is unresponsive.
  • Consider contacting your pharmacist for alternatives and guidance on securing medication.

How to prevent similar issues

  • Verify NDC and lot numbers on any substituted product.
  • Only obtain prescription medications through licensed providers and pharmacies.
  • Ask for full counseling on any beta-blocker switch or substitution.

Documentation advice

Keep the recall notice, bottle labels, and all correspondence with Teva. Document dates, conversations, and any adverse effects.

Product Details

NDCs: 45963-676-11 (50 mg, 100-tablet bottles) and 45963-676-96 (50 mg, 1,000-tablet bottles). Sold nationwide. Rx Only. Manufacturer: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Quantity: 67,043 bottles. Price: Unknown. Model/Lot information: Lot numbers a) 0486G251, 0487G251, 0488G251; Exp. 01/2027. Lot numbers b) 0486G252, 0487G253, 0488G252; Exp. 01/2027.

Key Facts

  • 67,043 bottles recalled
  • NDCs: 45963-676-11 and 45963-676-96
  • Lot numbers: 0486G251/0487G251/0488G251; Exp. 01/2027
  • Lot numbers: 0486G252/0487G253/0488G252; Exp. 01/2027
  • Nationwide distribution
  • Rx Only

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
ELECTRICALLACERATIONPOISONINGSUFFOCATIONOTHER

Product Details

Model Numbers
Lot#: a) 0486G251, 0487G251, 0488G251; Exp.: 01/2027
b) 0486G252, 0487G253, 0488G252; Exp.: 01/2027
UPC Codes
45963-676
45963-709
45963-677
+8 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more
Vehicles & Parts
HIGH

Chrysler Pacifica Radio Recall 2025 Over Rearview Camera Display Issue

Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.

Chrysler
A rearview
Read more